Entrada Therapeutics logo

Entrada Therapeutics share price today

(TRDA)

Entrada Therapeutics share price is $17.46 & ₹1,497.02 as on 3 Jan 2025, 2.30 'hrs' IST

$17.46

0.17

(0.98%)

Market is closed - opens 8 PM, 03 Jan 2025

View live Entrada Therapeutics share price in Dollar and Rupees. Guide to invest in Entrada Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Entrada Therapeutics. Get details on the Indian mutual funds that are investing in Entrada Therapeutics. Get Analyst recommendations and forecasts along with all the Entrada Therapeutics's financials.

Entrada Therapeutics share price movements

  • Today's Low: $17.16
    Today's High: $18.01

    Day's Volatility :4.72%

  • 52 Weeks Low: $11.35
    52 Weeks High: $21.79

    52 Weeks Volatility :47.91%

Entrada Therapeutics Returns

PeriodEntrada Therapeutics, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
1.29%
-10.0%
0.0%
6 Months
22.36%
-4.7%
0.0%
1 Year
22.97%
-0.9%
0.0%
3 Years
8.06%
-2.4%
-21.2%

Entrada Therapeutics Key Statistics

in dollars & INR

Previous Close
$17.29
Open
$17.41
Today's High
$18.01
Today's Low
$17.16
Market Capitalization
$647.0M
Today's Volume
$115.6K
52 Week High
$21.79
52 Week Low
$11.35
Revenue TTM
$215.2M
EBITDA
$61.3M
Earnings Per Share (EPS)
$1.44
PE Ratio
12.01
Profit Margin
25.53%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
16.42%

How to invest in Entrada Therapeutics from India?

It is very easy for Indian residents to invest directly in Entrada Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Entrada Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Entrada Therapeutics or TRDA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Entrada Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Entrada Therapeutics shares which would translate to 0.049 fractional shares of Entrada Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Entrada Therapeutics, in just a few clicks!

Returns in Entrada Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Entrada Therapeutics investment value today

Current value as on today

₹1,27,157

Returns

₹27,157

(+27.16%)

Returns from Entrada Therapeutics Stock

₹24,182 (+24.18%)

Dollar Returns

₹2,975 (+2.97%)

Indian investors sentiment towards Entrada Therapeutics

-73%

Period: Oct 4, 2024 to Jan 2, 2025. Change in 30 Days versus previous period

Search volume for Entrada Therapeutics on INDmoney from India has reduced in the last 30 days as on Jan 3, 2025. -73% less investors are searching Entrada Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Entrada Therapeutics

  • Baker Bros Advisors LP

    13.00%

  • Mpm Asset Management, LLC

    11.83%

  • 5AM Venture Management, LLC

    11.78%

  • T. Rowe Price Associates, Inc.

    8.15%

  • FMR Inc

    4.66%

  • HHG PLC

    4.57%

Analyst Recommendation on Entrada Therapeutics

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Entrada Therapeutics(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Entrada Therapeutics

What analysts predicted

Upside of 51.36%

Current:

$17.46

Target:

$26.43

Insights on Entrada Therapeutics

  • Price Movement

    In the last 1 month, TRDA stock has moved down by -14.9%
  • TRDA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 20.7% return, outperforming this stock by 6.7%
  • TRDA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 38.8% return, outperforming this stock by 37.8%
  • Price to Sales

    ForTRDA every $1 of sales, investors are willing to pay $2.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Entrada Therapeutics Technicals Summary

Sell

Neutral

Buy

Entrada Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Entrada Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Entrada Therapeutics, Inc.
-14.28%
22.36%
22.97%
8.06%
-27.81%
Regeneron Pharmaceuticals, Inc.
-4.97%
-31.12%
-21.91%
15.48%
91.62%
Biontech Se
-1.42%
42.28%
6.01%
-49.15%
155.61%
Alnylam Pharmaceuticals, Inc.
-6.56%
-6.26%
22.36%
42.41%
102.91%
Vertex Pharmaceuticals Incorporated
-11.88%
-15.14%
-3.23%
81.51%
79.75%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Entrada Therapeutics, Inc.
12.01
12.01
NA
1.07
0.16
0.07
NA
11.93
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Entrada Therapeutics, Inc.
Buy
$647.0M
-27.81%
12.01
25.53%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
91.62%
17.61
33.61%
Biontech Se
Buy
$27.3B
155.61%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
102.91%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
79.75%
32.84
-4.51%

About Entrada Therapeutics

entrada therapeutics is building the leading intracellular biologics company to transform the treatment of devastating diseases. entrada was co-founded in 2016 by 5am ventures, a leading life sciences venture capital firm.
Organization
Entrada Therapeutics
Employees
177
CEO
Mr. Dipal Doshi
Industry
Services

Management People of Entrada Therapeutics

NameTitle
Mr. Dipal Doshi
CEO & Director
Mr. Nathan J. Dowden
President & COO
Dr. Natarajan Sethuraman Ph.D.
President of Research & Development
Mr. Kory James Wentworth CPA
CFO & Treasurer
Dr. Jared Cohen J.D., Ph.D.
General Counsel
Ms. Kerry Robert M.S.
Senior Vice President of People
Ms. Karla MacDonald
Chief Corporate Affairs Officer
Mr. Kevin Healy Ph.D.
Senior Vice President of Regulatory Affairs

Important FAQs about investing in Entrada Therapeutics from India :

What is Entrada Therapeutics share price today?

Entrada Therapeutics share price today stands at $17.46, Open: $17.41 ; Previous Close: $17.29 ; High: $18.01 ; Low: $17.16 ; 52 Week High: $21.79 ; 52 Week Low: $11.35. The stock opens at $17.41, after a previous close of $17.29. The stock reached a daily high of $18.01 and a low of $17.16, with a 52-week high of $21.79 and a 52-week low of $11.35.

Can Indians buy Entrada Therapeutics shares?

Yes, Indians can invest in the Entrada Therapeutics (TRDA) from India.

With INDmoney, you can buy Entrada Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Entrada Therapeutics at zero transaction cost.

How can I buy Entrada Therapeutics shares from India?

It is very easy to buy Entrada Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Entrada Therapeutics be purchased?

Yes, you can buy fractional shares of Entrada Therapeutics with INDmoney app.

What are the documents required to start investing in Entrada Therapeutics stocks?

To start investing in Entrada Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Entrada Therapeutics

Today’s highest price of Entrada Therapeutics (TRDA) is $18.01.

Today’s lowest price of Entrada Therapeutics (TRDA) is $17.16.

What is today's market capitalisation of Entrada Therapeutics

Today's market capitalisation of Entrada Therapeutics TRDA is 647.0M

What is the 52 Week High and Low Range of Entrada Therapeutics

  • 52 Week High

    $21.79

  • 52 Week Low

    $11.35

What are the historical returns of Entrada Therapeutics?

  • 1 Month Returns

    -14.28%

  • 3 Months Returns

    22.36%

  • 1 Year Returns

    22.97%

  • 5 Years Returns

    -27.81%

Who is the Chief Executive Officer (CEO) of Entrada Therapeutics

Mr. Dipal Doshi is the current Chief Executive Officer (CEO) of Entrada Therapeutics.